Pacific Biosciences of California, Inc. (PACB)
NASDAQ·Healthcare·Medical - Devices
$1.57
-1.26%
Mkt Cap $471.12M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Feb 12, 2026 | $43.04M | $44.65M | +3.74% | -$0.19 | -$0.12 | +36.84% | — | — |
| Q4 2025 Nov 5, 2025 | $44.60M | $38.44M | -13.81% | -$0.16 | -$0.12 | +25.00% | — | — |
| Q3 2025 Aug 7, 2025 | $39.95M | $39.77M | -0.46% | -$0.18 | -$0.13 | +27.78% | — | — |
| Q2 2025 May 8, 2025 | $36.90M | $37.15M | +0.69% | -$0.19 | -$0.15 | +21.05% | — | — |
| Q1 2025 Feb 13, 2025 | $40.68M | $39.22M | -3.58% | -$0.20 | -$0.20 | +0.00% | — | — |
| Q4 2024 Nov 7, 2024 | $41.95M | $39.97M | -4.73% | -$0.22 | -$0.22 | +0.00% | — | — |
| Q3 2024 Aug 7, 2024 | $40.88M | $36.01M | -11.91% | -$0.24 | -$0.20 | +16.67% | — | — |
| Q2 2024 May 9, 2024 | $43.44M | $38.81M | -10.66% | -$0.28 | -$0.29 | -3.57% | — | — |
| Q1 2024 Feb 15, 2024 | $57.49M | $58.36M | +1.51% | -$0.29 | -$0.31 | -6.90% | — | — |
| Q4 2023 Oct 30, 2023 | $48.76M | $55.69M | +14.21% | -$0.33 | -$0.26 | +21.21% | — | — |
| Q3 2023 Aug 2, 2023 | $40.30M | $47.57M | +18.05% | -$0.32 | -$0.28 | +12.50% | — | — |
| Q2 2023 May 2, 2023 | $34.38M | $38.90M | +13.15% | -$0.33 | -$0.36 | -9.09% | — | — |
| Q1 2023 Feb 16, 2023 | $26.20M | $27.35M | +4.39% | -$0.36 | -$0.37 | -2.78% | — | — |
| Q4 2022 Nov 7, 2022 | $35.40M | $32.31M | -8.73% | -$0.33 | -$0.34 | -3.03% | — | — |
| Q3 2022 Aug 3, 2022 | $35.16M | $35.47M | +0.87% | -$0.32 | -$0.32 | +0.00% | — | — |
| Q2 2022 May 4, 2022 | $32.91M | $33.17M | +0.79% | -$0.31 | -$0.37 | -19.35% | — | — |
| Q1 2022 Feb 15, 2022 | $36.12M | $36.02M | -0.28% | -$0.28 | -$0.31 | -10.71% | — | — |
| Q4 2021 Nov 2, 2021 | $33.20M | $34.89M | +5.08% | -$0.21 | -$0.23 | -9.52% | — | — |
| Q3 2021 Aug 3, 2021 | $29.99M | $30.61M | +2.07% | -$0.21 | -$0.21 | +0.00% | — | — |
| Q2 2021 Apr 29, 2021 | $25.67M | $29.00M | +12.96% | -$0.45 | -$0.18 | +60.00% | — | — |